PULMOZYME 2500 U/2.5 ml, solution for inhalation by nebulizer 30 ampoules of 2.5 ml
Active ingredients: DÉSOXYRIBONUCLÉASE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for inhalation by nebulizer30 ampoules of 2.5 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PULMOZYME 2500 U/2,5 ml, solution pour inhalation par nébuliseur
- Pharmaceutical form
- solution pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 30 ampoule(s) polyéthylène de 2,5 ml
- Marketing authorisation holder
- ROCHE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Sept 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60866491CIP73646754CIP133400936467545Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DÉSOXYRIBONUCLÉASEsolution | 2500 U (2,5 mg) · 2,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.